Source - LSE Regulatory
RNS Number : 5585S
Alliance Pharma PLC
07 November 2023
 

For immediate release

7 November 2023

 

 

ALLIANCE PHARMA

("Alliance", "Company" or the "Group")

 

Appointment of Non-Executive Directors

 

Alliance Pharma plc (AIM: APH), the international healthcare group, is pleased to announce the appointment of Eva-Lotta Sjöstedt and Richard McKenzie as new independent Non-Executive Directors to strengthen the Board and support the delivery of the Company's growth strategy. Both Eva-Lotta and Richard will join the Board with immediate effect.

 

Eva-Lotta Sjöstedt

Eva-Lotta has in-depth knowledge of global consumer retail, supply chain and digital transformation and has held leadership roles in consumer-facing industries across Europe, Japan, China and the USA.

 

From 2016 to 2018, Eva-Lotta was CEO of Georg Jensen, the luxury jewellery and Scandinavian design brand, where she led a global team of 1,400 to implement an omni-channel turnaround in retail networks. Prior to this Eva-Lotta was CEO at Karstadt, a chain of premium department stores in Germany with a strong e-commerce presence. She started her career at IKEA, establishing the business in Japan where she worked for four years before becoming CEO of IKEA Netherlands and then Deputy Global Retail Manager. In this role she was responsible for IKEA's global multi-channel strategy and the implementation of its on and offline experiences throughout the entire global value chain.

 

Eva-Lotta is currently a NED at FTSE-250 listed Tritax Eurobox, which operates, manages and invests in real estate assets across Continental Europe. Eva-Lotta joined the Board of Tritax Eurobox in 2019 and she Chairs the ESG committee and sits on the Nomination and Management Engagement committees. She is a member of the Board of ELISA Oyj, a digital services and telecommunications company listed on Nasdaq Helsinki, and is also a member of the Supervisory Board of Metro AG, a German wholesale food specialist operating in 35 countries.

 

We believe that Eva-Lotta's experience will strengthen the European dimension of the Alliance Board whilst providing valuable e-commerce and multi-channel experience.

 

Richard McKenzie

Richard has international e-commerce, distribution, supply chain and logistics experience in the consumer, retail and technology sectors, along with particular expertise in the Asia-Pacific region having lived and worked in mainland China for 10 years.

 

From 2019 to 2023, Richard was Chief Commercial Officer and latterly President (Europe and Asia) for Ocado Solutions, driving the growth of this leading grocery e-commerce platform globally. During his tenure at Ocado Solutions, Richard led major new deals with distributors in Korea, Japan, Spain and Poland, and redesigned the B2B organisation of the business. Prior to this Richard was a strategy consultant for OC&C in London and China, building the company's presence in Asia-Pacific, before becoming a Senior Partner for the Consumer Goods and Retail practice of Oliver Wyman in Asia Pacific. During this time, he built extensive experience of the retail consumer market in China, and Asia-Pacific more broadly.

 

Richard is currently a Senior Advisor to McKinsey and Company.

 

We believe that Alliance will benefit from Richard's significant operational experience, particularly in the rapidly evolving distribution channels and cross border e-commerce markets in China and Asia-Pacific, whilst his career in consultancy will bring additional strategic oversight.

 

Jo LeCouilliard, Chair of Alliance, said:

"I am delighted to welcome Eva-Lotta and Richard to the Board and look forward to their contribution to support the delivery of our growth strategy. Eva-Lotta will bring significant additional global consumer expertise from her various senior executive leadership roles, and Richard will bring significant additional strategic and operational expertise, particularly in our important China market."

 

The following information is disclosed pursuant to Schedule Two, paragraph (g), of the AIM Rules for Companies.

 

Mrs Eva-Lotta Saga Sjöstedt, aged 56, has been a director of the following companies during the five years preceding the date of this announcement:

 

Current directorships

•           Metro AG

•           Tritax Eurobox PLC

•           Elisa Oyj

•           Pigos Holding AB

•           Tultan AB

•           Kuno Leadership Community AB

 

Directorships in the past five years:

 

None within past five years

 

Mrs Eva-Lotta Sjöstedt does not hold any ordinary shares of 1 pence each in the Company.

 

 

Mr Richard Alexander McKenzie, aged 51, has been a director of the following companies during the five years preceding the date of this announcement:

 

Current directorships

•           Strategy Max Ltd

•           Karakuri Ltd*

•           Ocado Intelligent Automation Ltd

Directorships in the past five years:

 

None within past five years

 

 

* Karakuri Ltd was placed into administration by its directors on 28 July 2023. All substantive trade and employee liabilities were settled in full, and shareholder loan notes were written off.

 

Mr Richard McKenzie does not hold any ordinary shares of 1 pence each in the Company.

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0)1249 466966

Cora McCallum, Head of Investor Relations & Corporate Communications

+ 44 (0)1249 705168

ir@allianceph.com

 

 

 

Buchanan

+ 44 (0)20 7466 5000

Mark Court / Sophie Wills

 

alliancepharma@buchanan.uk.com

 

 

 

Deutsche Numis (Nominated Adviser and Joint Broker)

+ 44 (0)20 7260 1000

Freddie Barnfield / Duncan Monteith / Sher Shah

 


 

Investec Bank plc (Joint Broker)

+ 44 (0)20 7597 5970

Corporate Broking: Patrick Robb / Maria Gomez de Olea

 

 

 

About Alliance

 

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.

Headquartered in the UK, the Group employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.

For more information on Alliance, please visit our websitewww.alliancepharmaceuticals.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZMGMLVNGFZM
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Alliance Pharma PLC (APH)

-0.35p (-0.99%)
delayed 15:40PM